Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Endothelin-1 transgenic mice develop glomerulosclerosis, interstitial fibrosis, and renal cysts but not hypertension.
B Hocher, … , W D Schleuning, F Theuring
B Hocher, … , W D Schleuning, F Theuring
Published March 15, 1997
Citation Information: J Clin Invest. 1997;99(6):1380-1389. https://doi.org/10.1172/JCI119297.
View: Text | PDF
Research Article Article has an altmetric score of 3

Endothelin-1 transgenic mice develop glomerulosclerosis, interstitial fibrosis, and renal cysts but not hypertension.

  • Text
  • PDF
Abstract

The human endothelin-1 (ET-1) gene under the control of its natural promoter was transferred into the germline of mice. The transgene was expressed predominantly in the brain, lung, and kidney. Transgene expression was associated with a pathological phenotype manifested by signs such as age-dependent development of renal cysts, interstitial fibrosis of the kidneys, and glomerulosclerosis leading to a progressive decrease in glomerular filtration rate. This pathology developed in spite of only slightly elevated plasma and tissue ET-1 concentrations. Blood pressure was not affected even after the development of an impaired glomerular filtration rate. Therefore, these transgenic lines provide a new blood pressure-independent animal model of ET-1-induced renal pathology leading to renal fibrosis and fatal kidney disease.

Authors

B Hocher, C Thöne-Reineke, P Rohmeiss, F Schmager, T Slowinski, V Burst, F Siegmund, T Quertermous, C Bauer, H H Neumayer, W D Schleuning, F Theuring

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1995 Total
Citations: 4 3 1 4 5 9 6 6 10 13 11 10 9 8 8 9 13 13 11 13 7 13 19 11 19 19 13 17 2 1 287
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article in year 2010 (9)

Title and authors Publication Year
Lack of both bradykinin B1 and B2 receptors enhances nephropathy, neuropathy, and bone mineral loss in Akita diabetic mice
M Kakoki, KA Sullivan, C Backus, JM Hayes, SS Oh, K Hua, AM Gasim, H Tomita, R Grant, SB Nossov, HS Kim, JC Jennette, EL Feldman, O Smithies
Proceedings of the National Academy of Sciences 2010
Endothelin—Biology and disease
A Khimji, DC Rockey
Cellular Signalling 2010
At the heart of tissue: endothelin system and end-organ damage
M Iglarz, M Clozel
Clinical Science 2010
Therapeutic potential of endothelin receptor antagonists for chronic proteinuric renal disease in humans
M Barton
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2010
Plasma C-terminal pro-endothelin-1 is associated with target-organ damage in African Americans with hypertension
A Habib, MA Al-Omari, M Khaleghi, NG Morgenthaler, J Struck, A Bergmann, TH Mosley, ST Turner, IJ Kullo
American Journal of Hypertension 2010
Endothelin-1 Increases Collagen Accumulation in Renal Mesangial Cells by Stimulating a Chemokine and Cytokine Autocrine Signaling Loop
MS Simonson, F Ismail-Beigi
The Journal of biological chemistry 2010
Renoprotective effects of paricalcitol on gentamicin-induced kidney injury in rats
JW Park, EH Bae, IJ Kim, SK Ma, C Choi, JU Lee, SW Kim
American journal of physiology. Renal physiology 2010
Endothelin-1 Increases Glomerular Permeability and Inflammation Independent of Blood Pressure in the Rat
MA Saleh, EI Boesen, JS Pollock, VJ Savin, DM Pollock
Hypertension 2010
Molecular Pathology of Liver Diseases
SP Monga
2010

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 2 patents
76 readers on Mendeley
See more details